[1]
Lisni, I., Lestari, K. and Andalusia, L.R. 2025. Polypharmacy in Type 2 Diabetes Patients of the PROLANIS Program in Indonesia: Identification of Potential Drug-Drug Interaction . Jordan Journal of Pharmaceutical Sciences. 18, 1 (Mar. 2025), 245–257. DOI:https://doi.org/10.35516/jjps.v18i1.2783.